Market Overview

UPDATE: Novartis Posts Upbeat Q2 Profit

Related NVS
Almost The Whole World In This ETF's Hands
Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares
CTI Bio's late-stage study of lead product candidate pacritinib shows mixed results; full clinical hold still in effect (Seeking Alpha)

Novartis AG (NYSE: NVS) reported a rise in its second-quarter net profit.

Novartis's quarterly net profit increased to $2.71 billion, versus $2.70 billion, in the year-ago period. However, analysts were expecting a net profit of $2.52 billion.

Its net sales declined 4% to $14.3 billion.

Novartis shares closed at $56.36 yesterday.

Posted-In: profitEarnings News


Related Articles (NVS)

View Comments and Join the Discussion!